Remember those colorful “grow capsules” that blossom into animal-shaped sponges in water? Using a similar idea, scientists have developed biodegradable polymer grafts that, when surgically placed in damaged vertebrae, should grow to be just the right size and shape to fix the spinal column.
The researchers present their work today at the 251st National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world’s largest scientific society, is holding the meeting here through Thursday. It features more than 12,500 presentations on a wide range of science topics.
“The overall goal of this research is to find ways to treat people with metastatic spinal tumors,” says Lichun Lu, Ph.D. “The spine is the most common site of skeletal metastases in cancer patients, but unlike current treatments, our approach is less invasive and is inexpensive.”
Often, removing extensive spinal tumors requires taking out the entire bone segment and adjacent intervertebral discs from the affected area. In this case, something must fill the large void to maintain the integrity of the spine and protect the spinal cord.
There are typically two surgical choices in cases of extensive spinal metastases. In the more aggressive and invasive option, the surgeon opens the chest cavity from the front of the patient, which provides enough room to insert metal cages or bone grafts to replace the missing fragment. The other approach is less invasive, requiring just a small cut in the back or posterior, but only offers enough space for the surgeon to insert short expandable titanium rods, which are costly.
To develop a less expensive graft compatible with the posterior spinal surgery option, Lu, who is at the Mayo Clinic, and her postdoctoral fellow, Xifeng Liu, Ph.D., sought a material that could be dehydrated down to a size compatible with posterior spinal surgery, and then, once implanted, absorb fluids from the body, expanding to replace the missing vertebrae.
The researchers started by crosslinking oligo[poly(ethylene glycol) fumarate] to create a hollow hydrophilic cage — the scaffold of the graft — which could then be filled with stabilizing materials, as well as therapeutics. “When we designed this expandable tube, we wanted to be able to control the size of the graft so it would fit into the exact space left behind after removing the tumor,” Lu says. The researchers also needed to control the kinetics of the expansion, because if the cage expands too quickly, a surgeon may not have enough time to position it correctly, while a slow expansion could mean a longer-than-necessary surgery.
Modifying the degree and timing of the polymer graft’s expansion was a matter of chemistry, Liu says. “By modulating the molecular weight and charge of the polymer, we are able to tune the material’s properties,” he says. The researchers studied the effects of these chemical changes by observing the polymer grafts’ expansion rates under conditions that mimic the spinal column environment in the lab. This information is key for determining the optimal size of a spinal implant for use in restorative surgery. The team identified a combination of materials that are biocompatible in animals and that they believe will work in humans.
Lu says her lab’s next step is to study the grafts in cadavers and simulate an in-patient procedure. Their goal is to initiate clinical trials within the next few years.
